+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Nebivolol"

Beta Blockers Global Market Report 2024 - Product Thumbnail Image

Beta Blockers Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Nebivololo Mylan - API Insight, 2022 - Product Thumbnail Image

Nebivololo Mylan - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Nebivololo Mylan- Drug Insight, 2019 - Product Thumbnail Image

Nebivololo Mylan- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Nebivolol is a beta-blocker drug used to treat hypertension and other cardiovascular diseases. It works by blocking the action of certain natural substances in the body, such as epinephrine, that affect the heart and blood vessels. This helps to reduce blood pressure, heart rate, and strain on the heart. Nebivolol is also used to treat angina, or chest pain caused by reduced blood flow to the heart. Nebivolol is available in both generic and brand-name formulations. It is typically taken once daily, with or without food. Common side effects include dizziness, fatigue, and nausea. Nebivolol is a popular choice for treating hypertension and other cardiovascular diseases due to its effectiveness and low risk of side effects. It is also relatively inexpensive compared to other beta-blockers. Some companies that produce Nebivolol include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more